Bausch Health Companies Inc (BHC)
$7.41
0.11 (1.46%)
BHC Stock Quote Delayed 30 Minutes
BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024
BHC stock results show that Bausch Health Companies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
2.66B
PE Ratio
-6.02
EPS
-1.23
Volume (Avg. Vol.)
2.28M
Day's Range
$7.41 - $7.64
52-Week Range
$5.57 - $11.46
Dividend & Yield
N/A (N/A)
BHC Stock Predictions, Articles, and Bausch Health Companies Inc News
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting.
Bausch Health (BHC) Stock Plunges 50% on Patent News
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.
Billionaire Carl Icahn Is Betting Big on These 5 Stocks. Here’s Why.
Corporate raider Carl Icahn no longer manages money for external clients. However, he still manages more than $21 billion of 13F assets for his family…
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022.
BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today
Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today.
BLCO Stock IPO: When Does Bausch + Lomb Go Public? What Is the Bausch + Lomb IPO Price Range?
Here's what investors may want to know about the upcoming BLCO stock IPO, as Bausch + Lomb is split off from its parent company this week.
BHC Stock: 9 Things to Know as Jim Cramer Buys Bausch Health
The Mad Money host announced a new position in Bausch Health amid the spread of the omicron variant. Here's what you should know.
Bausch Health Earnings: BHC Stock Takes a Big 7% Hit on Mixed Q4
Bausch Health (BHC) earnings for the pharmaceutical company's fourth quarter of 2019 have BHC stock falling hard on Wednesday.
3 Big Stock Charts for Tuesday: Bausch Health, Booking Holdings, and Proofpoint
Tuesday's big stock charts focus on 3 names facing near-term inflection points that should drive near-term direction.
4 Top Stock Trades for Tuesday: MCD, UAA, Berkshire
Berkshire Hathaway, McDonald's, Under Armour and Bausch Health were our top stock trades from Monday. Here's a look at the charts.
Stock Market Today: How Many Times Will the Fed Cut Rates?
After six straight sessions of losses, it was a welcomed sight to see stocks rally on Tuesday. Here's what happened on the stock market today.
All Signals Are Positive for Buying Abbott Laboratories
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow
Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.
